The Miami Entrepreneur

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

Read Time:7 Second

Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
Next post Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs